Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COM
-
Number of holders
-
24
-
Total 13F shares, excl. options
-
2,921,778
-
Shares change
-
-1,495,829
-
Total reported value, excl. options
-
$2,436,675
-
Value change
-
-$1,654,962
-
Put/Call ratio
-
1.06%
-
Number of buys
-
8
-
Number of sells
-
-19
-
Price
-
$0.8317
Significant Holders of Protalix BioTherapeutics, Inc. - COM (PLX) as of Q4 2021
43 filings reported holding PLX - Protalix BioTherapeutics, Inc. - COM as of Q4 2021.
Protalix BioTherapeutics, Inc. - COM (PLX) has 24 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2,921,778 shares
.
Largest 10 shareholders include MORGAN STANLEY (1,292,913 shares), GROUP ONE TRADING, L.P. (630,546 shares), Phoenix Holdings Ltd. (244,113 shares), Spire Wealth Management (125,800 shares), BlackRock Inc. (114,398 shares), TWO SIGMA ADVISERS, LP (99,900 shares), JANE STREET GROUP, LLC (85,658 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (81,950 shares), SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC (42,900 shares), and COMMONWEALTH EQUITY SERVICES, LLC (40,290 shares).
This table shows the top 24 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.